• Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Care Continuum Alliance rebrands to focus on population health

Article

Quality and research initiatives in engagement and the value of investment in population health programs will be a focus in 2014.

The Care Continuum Alliance has changed its name to the Population Health Alliance (PHA) in order to better reflect the nature of the organization and the work its members are doing. The organization has represented population health, disease management, wellness and prevention stakeholders for over a decade.

“As the health system has developed, we recognized the need to have a name that reflects the true breadth and depth of our membership and what this organization supports,” says Isabel Estrada-Portales, PHA Director of Communications. “We are here to advance the principles of population health throughout the healthcare system,”

The name change is accompanied by the launch of a newly revamped website, which offers information and services for its members and the public, and aims to provide a more comprehensive understanding of the organization’s research initiatives, advocacy efforts and opportunities for collaboration.                                                                                                                                                      

 “Our goal continues to be to form a broad community that brings together all those innovating and delivering new approaches and technologies in order to support and enhance the success of our stakeholders,” says Fred Goldstein, PHA Interim Executive Director and Chair of the Board. “This name change was inspired by input from our membership, as an acknowledgement of the growing acceptance of population health management as one of the central strategies now being employed across the care continuum to improve quality of care while reducing avoidable healthcare costs.”

Quality and research initiatives in areas such as engagement and the value of investment in population health programs will be a focus for the organization in 2014. 

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.